Hanwha Chem Seeks To Raise $395 Million To Attract Foreign Investors
This article was originally published in PharmAsia News
Executive Summary
Hanwha Chemical, a drug maker in South Korea listed in Singapore, is attempting to raise $395 million to reduce some of the debt it incurred during a recent acquisition binge to attract more foreign investors.